Revolution Medicines, Inc.
RVMD
$203.71
$1.710.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3.94B | 1.91B | 2.03B | 1.93B | 2.14B |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 90.37M | 59.83M | 49.36M | 45.98M | 39.27M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.03B | 1.97B | 2.08B | 1.98B | 2.18B |
|
|
|||||
| Total Current Assets | 4.03B | 1.97B | 2.08B | 1.98B | 2.18B |
| Net Property, Plant & Equipment | 162.45M | 161.37M | 165.28M | 167.38M | 147.05M |
| Long-term Investments | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Goodwill | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Total Other Intangibles | 55.80M | 55.80M | 55.80M | 55.87M | 56.14M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 62.07M | 54.05M | 43.79M | 36.58M | 35.34M |
| Total Assets | 4.32B | 2.25B | 2.35B | 2.25B | 2.43B |
|
|
|||||
| Total Accounts Payable | 88.42M | 80.54M | 64.62M | 74.85M | 56.76M |
| Total Accrued Expenses | 243.74M | 189.19M | 201.48M | 146.21M | 114.22M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.75M | 16.61M | 16.47M | 16.33M | 13.09M |
| Total Finance Division Other Current Liabilities | 5.15M | 3.26M | 7.86M | 8.24M | 462.00K |
| Total Other Current Liabilities | 5.15M | 3.26M | 7.86M | 8.24M | 462.00K |
| Total Current Liabilities | 354.06M | 289.60M | 290.42M | 245.62M | 184.53M |
|
|
|||||
| Total Current Liabilities | 354.06M | 289.60M | 290.42M | 245.62M | 184.53M |
| Long-Term Debt | 1.04B | 280.64M | 268.45M | 256.51M | 245.08M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 137.74M | 140.02M | 142.23M | 142.14M | 119.70M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 189.25M | 43.56M | 22.11M | 10.75M | 14.89M |
| Total Liabilities | 1.72B | 753.82M | 723.21M | 655.02M | 564.20M |
|
|
|||||
| Common Stock & APIC | 6.58B | 4.82B | 4.50B | 4.10B | 4.06B |
| Retained Earnings | -3.97B | -3.32B | -2.87B | -2.50B | -2.20B |
| Treasury Stock & Other | -5.95M | -622.00K | 3.24M | 3.12M | 1.30M |
| Total Common Equity | 2.61B | 1.50B | 1.63B | 1.60B | 1.87B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.61B | 1.50B | 1.63B | 1.60B | 1.87B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.61B | 1.50B | 1.63B | 1.60B | 1.87B |
|
|
|||||